Patents Assigned to Medtronic, Inc.
-
Patent number: 12144637Abstract: Devices, systems, and techniques are disclosed for managing electrical stimulation therapy and/or sensing of physiological signals such as brain signals. For example, a system may assist a clinician in identifying one or more electrode combinations for sensing a brain signal. In another example, a user interface may display brain signal information and values of a stimulation parameter at least partially defining electrical stimulation delivered to a patient when the brain signal information was sensed.Type: GrantFiled: December 31, 2020Date of Patent: November 19, 2024Assignee: Medtronic, Inc.Inventors: Evan D. Schnell, Scott R. Stanslaski, Ilan D. Gordon, Steven M. Goetz, Hijaz M. Haris, Eric J. Panken, Timothy R. Abraham, Thomas L. Chouinard, Susan Heilman Kilbane, Karan Chitkara, Christopher M. Arnett, Alicia W. Thompson, Kevin C. Johnson, Ankush Thakur, Lukas Valine, Christopher L. Pulliam, Brady N. Fetting, Rucha Gokul G. Samant, Andrew H. Houchins, Caleb C. Zarns
-
Patent number: 12138418Abstract: An implantable infusate spread promoting system configured to enable improved dispersion of delivered infusate. The system including an implantable device configured to enable infusate delivery within a body of a patient, and an implantable manually actuatable flushing pump configured to remove and re-inject a quantity of fluid with each actuation to promote improved dispersion of the delivered infusate.Type: GrantFiled: October 5, 2022Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Touby A. Drew, Jeffrey P. Bodner
-
Patent number: 12138442Abstract: An external coil system for a transcutaneous energy transfer system (TETS), the external coil being configured to transfer energy sufficient to power and implantable blood pump. The system includes a housing containing the external coil, the housing includes a thermal insulating base, the external coil being partially disposed within the thermal insulating base and a thermally conductive plastic, the external coil being partially disposed within the thermally conductive plastic.Type: GrantFiled: May 3, 2021Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: David J. Peichel, Ramesh Raghupathy
-
Patent number: 12137932Abstract: Assemblies and methods provide for implantation of multiple medical leads to a defined space within the body, such as the epidural space, through a single entry. A catheter having multiple lumens or alternatively a single oblong lumen may be used. A distal end of the catheter enters the defined space through the single entry such that the distal ends of the multiple lumens or the oblong lumen are present in the defined space. Medical leads are introduced through the multiple lumens or the oblong lumen into the defined space. In some cases, the distal end of the catheter may be deflectable to direct the medical leads within the defined space. In other cases, sheaths may be present within each lumen of the catheter where the sheaths may be extended into the defined space and deflect to direct the medical leads that are being passed through a lumen of the sheaths.Type: GrantFiled: August 31, 2020Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Eric H. Bonde, Phillip C. Falkner, John B. Horrigan, Stuart R. MacDonald, Madeline A. Mannion
-
Patent number: 12138461Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.Type: GrantFiled: August 2, 2021Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Wade M. Demmer, Yong K. Cho, Mark K. Erickson, Todd J. Sheldon
-
Patent number: 12138441Abstract: A TETS having an external controller having a power source, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and an implantable blood pump. The implantable controller has a battery configured to receive power from the receiving coil and the external controller is configured to categorize power transfer states based on predetermined thresholds of efficiency and power demand, and user display states (associated with optional configurable notifications) based on the power transfer states and predetermined temperature thresholds of the transmission coil.Type: GrantFiled: February 1, 2021Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Eric A. Schilling, John Rudser, David J. Peichel, Brian D. Kuhnley
-
Patent number: 12138463Abstract: Systems, apparatus, methods and computer-readable storage media facilitating trusted pairing between an implantable medical device (IMD) and an external device are provided. In one embodiment, an IMD includes a housing configured to be implanted within a patient, a memory and circuitry within the housing and a processor that executes executable components stored in the memory.Type: GrantFiled: November 13, 2023Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Matthew R Yoder, Gary P. Kivi, Richard A. Sanden, Bo Zhang, Eric Daniel James Dorphy
-
Patent number: 12138050Abstract: A biocompatible medical device may include an electrochemical sensor including a common reference electrode; at least one counter electrode; and a work electrode platform comprising a plurality of respective work electrodes, each respective work electrode electrically coupled to the common reference electrode and comprising a respective reagent substrate configured to react with a respective analyte to produce a respective signal indicative of a concentration of the respective analyte; and processing circuitry operatively coupled to the electrochemical sensor, and configured to receive from the electrochemical sensor a plurality of signals from the plurality of respective work electrodes; identify the respective signal corresponding to a respective selected work electrode; and process the identified signal to determine the concentration of the respective analyte associated with the respective selected work electrode.Type: GrantFiled: September 1, 2023Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Daniel Hahn, Mohsen Askarinya, James K. Carney, Patrick W. Kinzie, Jennifer Lorenz Marckmann, Randal C. Schulhauser, Santhisagar Vaddiraju, Akhil Srinivasan, David Probst, Alejo Chavez Gaxiola
-
Patent number: 12138413Abstract: An intrathecal drug delivery system configured to monitor one or more physiological conditions of the patient to look for opportunities to time medicament delivery to coincide with patient activity inferring heightened cerebrospinal fluid oscillations, thereby improving dispersion of the medicament within the intrathecal space of the patient. The intrathecal drug delivery system includes an implantable medical pump, one or more physiological sensors, and an external programmer configured to program the implantable medical pump with a treatment protocol specifying at least one period of time during which a specified quantity of medicament is to be administered during which the implantable medical pump utilizes data from the one or more physiological sensors to time delivery of the medicament.Type: GrantFiled: December 20, 2021Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventor: Jeffrey Bodner
-
Patent number: 12138440Abstract: A method of managing a speed of implantable blood pump. The implantable blood pump is in communication with an internal battery and a transcutaneous energy transfer system (TETS). The method includes starting the pump at a programmed set speed. The speed of the pump is decreased from the programmed set speed to a minimum set speed if either a capacity of the internal battery is less than a predetermined reserve level and TETS power is unavailable, or there is insufficient TETS power to maintain the programmed set speed. The speed of the pump is progressively decreased from the programmed set speed if there is insufficient power to maintain the programmed set speed.Type: GrantFiled: June 30, 2021Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Eric A. Schilling, Joel B. Artmann, Jason C. Lee, David I. Siegfried
-
Patent number: 12137924Abstract: A surgical method treats infections on a lead positioned at least partially within a patient's body. The surgical method includes uncoupling the lead from a pulse generator. The lead is then coupled to an ultrasound wave generator. Ultrasound waves are propagated from the ultrasound wave generator through the lead. Systems are disclosed.Type: GrantFiled: March 29, 2023Date of Patent: November 12, 2024Assignee: Medtronic, IncInventors: Alan Cheng, Jian Cao, Zhongping Yang
-
Patent number: 12138459Abstract: Devices, systems, and techniques include determining spatial relationships between electrodes implanted within a patient. In one example, a medical device delivers, via a first electrode, an electrical stimulus and senses, for each other electrode, a respective electrical signal indicative of the electrical stimulus. The medical device determines, for each other electrode, a respective value for each respective electrical signal. The medical device determines, based on the respective values for each respective electrical signal and values of tissue conductivity of tissues of the patient interposed between the first electrode and the other electrodes, spatial relationships between the first electrode and each other electrode of the plurality of electrodes.Type: GrantFiled: January 13, 2023Date of Patent: November 12, 2024Assignee: Medtronic, Inc.Inventors: Jerel K. Mueller, Andrew J. Cleland
-
Patent number: 12133936Abstract: A surgical device configured to surround an implantable medical device that includes a collagen membrane and a coating embedded in the membrane, the coating including at least one active pharmaceutical ingredient.Type: GrantFiled: January 6, 2021Date of Patent: November 5, 2024Assignee: Medtronic, IncInventors: Christian S. Nielsen, Sean Chen, Anne R. Kamm, Paul C. Ray
-
Patent number: 12133977Abstract: A controller for an implantable blood pump includes processing circuitry configured to initiate a suction response algorithm if a combination of a number of detected suction events multiplied by a suction event variable and a number of non-suction events multiplied by a non-suction event variable exceed a predetermined threshold.Type: GrantFiled: November 18, 2022Date of Patent: November 5, 2024Assignee: Medtronic, Inc.Inventor: D'Anne E. Kudlik
-
Patent number: 12133984Abstract: Techniques for evaluating cardiac electrical dyssynchrony are described. In some examples, an activation time is determined for each of a plurality of torso-surface potential signals. The dispersion or sequence of these activation times may be analyzed or presented to provide variety of indications of the electrical dyssynchrony of the heart of the patient. In some examples, the locations of the electrodes of the set of electrodes, and thus the locations at which the torso-surface potential signals were sensed, may be projected on the surface of a model torso that includes a model heart. The inverse problem of electrocardiography be solved to determine electrical activation times for regions of the model heart based on the torso-surface potential signals sensed from the patient.Type: GrantFiled: June 4, 2021Date of Patent: November 5, 2024Assignee: Medtronic, Inc.Inventors: Subham Ghosh, Jeffrey M. Gillberg, Robert W. Stadler
-
Patent number: 12133982Abstract: Devices, systems, and techniques for controlling electrical stimulation therapy are described. In one example, a system may be configured to deliver electrical stimulation therapy to a patient, the electrical stimulation therapy comprising a plurality of therapy pulses at a predetermined pulse frequency over a period of time and deliver, over the period of time, a plurality of control pulses interleaved with at least some therapy pulses of the plurality of therapy pulses. The system may also be configured to sense, after one or more control pulses and prior to an immediately subsequent therapy pulse of the plurality of therapy pulses, a respective evoked compound action potential (ECAP), adjust, based on at least one respective ECAP, one or more parameter values that at least partially defines the plurality of therapy pulses, and deliver the electrical stimulation therapy to the patient according to the adjusted one or more parameter values.Type: GrantFiled: September 24, 2021Date of Patent: November 5, 2024Assignee: Medtronic, Inc.Inventors: David A. Dinsmoor, Heather Diane Orser, Scott R. Stanslaski, Erik J. Peterson
-
Patent number: 12133985Abstract: Far field telemetry communications are conducted during recharge sessions between an external device and an implantable medical device. The two devices may not have been previously paired together for far field telemetry and may have been paired with other devices for far field telemetry during previous recharge sessions and/or programming sessions. Embodiments provide for temporary bonding of the two devices for far field telemetry during the recharge session. The implantable medical device of the recharge session may maintain a programming bond with an external device other than the external device conducting the recharge session. Safeguards against establishment of inadvertent programming sessions between the external device that has conducted a recharge session and implantable medical devices that may or may not be bonded to that external device are provided.Type: GrantFiled: December 23, 2020Date of Patent: November 5, 2024Assignee: Medtronic, Inc.Inventors: Reid K. Bornhoft, Garrett R. Sipple, Nathan A. Torgerson
-
Publication number: 20240358499Abstract: Prosthetic heart valves each includes a link extending along an axial direction and an axial frame. The axial frame includes a plurality of struts comprising a plurality of inner struts pivotally attached to a plurality of outer struts at a plurality of pivot nodes. A first pivot node of the plurality of pivot can be attached to the link and a second pivot node of the plurality of pivot nodes can move relative to the link in the axial direction. Methods of radially expanding a prosthetic heart valve can comprise radially expanding the radially expandable frame from a radially retracted orientation to a radially expanded orientation while the second pivot node axially translates relative to the link.Type: ApplicationFiled: December 8, 2023Publication date: October 31, 2024Applicant: Medtronic, Inc.Inventor: Karl L. OLNEY
-
Publication number: 20240358508Abstract: An advancer includes an advancer hub and an advancer shaft extending distally from the advancer hub. The advancer shaft includes a proximal end, a distal end, and a lumen extending from the proximal end to the distal end. The advancer shaft is configured to be disposed around an outer shaft of a delivery catheter, and includes a split line configured to enable splitting the shaft to enable removal of the shaft from the outer shaft. The advancer hub configured to be mounted on the outer shaft of the delivery catheter, and includes a parting line to enable splitting of the advancer hub.Type: ApplicationFiled: February 21, 2024Publication date: October 31, 2024Applicant: Medtronic, Inc.Inventors: Marc A. Anderson, Luke A. Clarke, Alan Thomas McGuinn, Matthew P. Norgrove, Timothy Desmond Farrell, Conleth A. Mullen, Cian Walsh, Mark Casley
-
Patent number: 12127778Abstract: Devices, systems, and methods for more efficiently ablating tissue with pulsed field ablation energy while minimizing collateral injury to non-target tissue. In one embodiment, a system for ablating tissue at a treatment site comprises: an energy delivery device; and a control unit including: a source of impedance-modifying fluid in fluid communication with the energy delivery device; an energy generator in electrical communication with the energy delivery device, the energy generator being configured to transmit energy to the energy delivery device and the energy delivery device being configured to deliver energy to the treatment site; and processing circuitry configured to control delivery of the impedance-modifying fluid from the energy delivery device to the treatment site. In one embodiment, a method for ablating tissue comprises delivering an impedance-modifying fluid to a treatment site and delivering pulsed field ablation energy to the treatment site.Type: GrantFiled: January 31, 2019Date of Patent: October 29, 2024Assignee: Medtronic, Inc.Inventors: Mark T. Stewart, Brian T. Howard